iBstone AuraLink vs RCA In-Ear

The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This behind-the-ear device ranks #33 among 65 tested OTC hearing aids, placing it in the top 49% of its category. In our testing, the AuraLink shows a distinctive performance profile with notable strengths in audio entertainment. Music streaming scored a solid 3.6/5, measuring 1.68 points above the category average—a standout result for an OTC device. Feedback handling earned an excellent 5.0/5, sitting 0.46 points above average, meaning users should experience minimal whistling during daily wear. However, speech clarity presents a different picture. Speech in quiet scored a mixed 2.3/5, falling 0.47 points below the category average of 2.79. Speech in noise performance was low at 1.0/5, trailing the already modest category average by 0.48 points. Own-voice comfort scored 2.7/5, slightly above average but only mixed in absolute terms. At $649, the AuraLink faces competition from alternatives offering similar or better sound performance at lower prices, including the iHear MatriX and Olive Union Max. The AuraLink may appeal to users who prioritize music and media streaming over speech enhancement, but those seeking stronger speech clarity should explore other options in this price range.

The RCA In-Ear is a budget OTC hearing aid priced at $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC category at #64 of 65 devices tested. Speech performance is a significant weakness for this device. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, while speech in noise also scores 1.0/5, sitting 0.48 points below average. These low absolute scores indicate limited benefit for understanding conversation in most listening situations. Music streaming scored 0.0/5, measuring 1.92 points below the category average—this device is not suitable for audio entertainment. The RCA In-Ear does show strength in feedback handling, scoring an excellent 5.0/5, which is 0.46 points above the category average. Own-voice comfort is mixed at 2.6/5, essentially matching the category average with only a 0.09-point advantage. The rechargeable battery design offers convenience for daily use. At this price point, consumers have substantially higher-performing alternatives. Devices like the Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and several others in the same budget range deliver meaningfully better speech clarity and overall sound quality. The RCA In-Ear may appeal to those prioritizing feedback-free operation above all else, but most users seeking improved hearing will find better value elsewhere in the OTC market.